SAMBO, MARGHERITA
 Distribuzione geografica
Continente #
AS - Asia 1.207
NA - Nord America 983
EU - Europa 884
SA - Sud America 282
AF - Africa 31
Totale 3.387
Nazione #
US - Stati Uniti d'America 933
RU - Federazione Russa 386
SG - Singapore 386
CN - Cina 350
IT - Italia 271
BR - Brasile 240
KR - Corea 152
HK - Hong Kong 116
VN - Vietnam 91
DE - Germania 47
IN - India 44
GB - Regno Unito 38
CA - Canada 28
IE - Irlanda 24
FI - Finlandia 20
AR - Argentina 17
MX - Messico 17
AT - Austria 16
BD - Bangladesh 12
ES - Italia 12
SE - Svezia 11
FR - Francia 10
NL - Olanda 10
ZA - Sudafrica 10
EG - Egitto 7
IQ - Iraq 7
AE - Emirati Arabi Uniti 6
EC - Ecuador 6
ID - Indonesia 6
LT - Lituania 6
PL - Polonia 6
BE - Belgio 5
JP - Giappone 5
PY - Paraguay 5
TR - Turchia 5
CL - Cile 4
HR - Croazia 4
IR - Iran 4
MA - Marocco 4
SA - Arabia Saudita 4
UA - Ucraina 4
VE - Venezuela 4
AZ - Azerbaigian 3
CH - Svizzera 3
LU - Lussemburgo 3
NG - Nigeria 3
PE - Perù 3
PK - Pakistan 3
UZ - Uzbekistan 3
CI - Costa d'Avorio 2
CO - Colombia 2
CZ - Repubblica Ceca 2
JO - Giordania 2
KE - Kenya 2
TW - Taiwan 2
AL - Albania 1
BB - Barbados 1
BH - Bahrain 1
BO - Bolivia 1
DK - Danimarca 1
DM - Dominica 1
DO - Repubblica Dominicana 1
EE - Estonia 1
ET - Etiopia 1
GA - Gabon 1
GE - Georgia 1
HN - Honduras 1
JM - Giamaica 1
KZ - Kazakistan 1
LA - Repubblica Popolare Democratica del Laos 1
MY - Malesia 1
NO - Norvegia 1
PT - Portogallo 1
RO - Romania 1
SY - Repubblica araba siriana 1
TN - Tunisia 1
Totale 3.387
Città #
Dallas 458
Singapore 249
Hefei 178
Seoul 152
Santa Clara 125
Moscow 119
Hong Kong 116
Milan 112
Beijing 61
Ashburn 49
Ho Chi Minh City 38
Los Angeles 34
Bengaluru 32
Florence 32
São Paulo 25
Dublin 24
Hanoi 20
Munich 20
Siena 20
New York 19
Redondo Beach 18
Buffalo 13
Lappeenranta 13
Nuremberg 13
Rome 12
The Dalles 11
Messina 10
Mexico City 9
Seattle 9
Chandler 8
Curitiba 8
Montreal 8
Vienna 8
Brooklyn 7
Chicago 7
Orem 7
Toronto 7
Atlanta 6
Boston 6
Brasília 6
Chennai 6
Frankfurt am Main 6
Porto Alegre 6
Rio de Janeiro 6
Brussels 5
Cairo 5
Hải Dương 5
Johannesburg 5
Poplar 5
Stockholm 5
Tokyo 5
Zarautz 5
Calgary 4
Charlotte 4
Denver 4
Genoa 4
Guangzhou 4
Houston 4
João Pessoa 4
Lauterbourg 4
Lograto 4
London 4
Naples 4
Ninh Bình 4
Portsmouth 4
Querétaro 4
Salt Lake City 4
Tehran 4
Turku 4
Warsaw 4
Zagreb 4
Baku 3
Bắc Giang 3
Cambridge 3
Campo Grande 3
Cape Town 3
Düsseldorf 3
Helsinki 3
Jakarta 3
Kent 3
Luxembourg 3
Manchester 3
Ottawa 3
Princeton 3
Quarrata 3
San Gavino Monreale 3
St Louis 3
Tashkent 3
Topeka 3
Vancouver 3
Zola Predosa 3
Abidjan 2
Amman 2
Ankara 2
Bandung 2
Barueri 2
Bauru 2
Blumenau 2
Bologna 2
Bragança Paulista 2
Totale 2.287
Nome #
Programma di vaccinazione antiMpox e screening infettivologico: opportunità di prevenzione in differenti categorie a rischio 256
Discordant liver fibrosis predictors in virologically suppressed people living with hiv without hepatitis virus infection 157
Patient profile characteristics when choosing different Dolutegravir-based dual therapies: impact on long term efficacy and durability 130
Transcriptomic analysis after SARS-CoV-2 mRNA vaccination reveals a specific gene signature in low-responder hemodialysis patients 123
Urinary tract infections caused by Gram-negative bacteria in elderly hospitalized patients: epidemiology, clinical features and outcomes in the era of antimicrobial resistance 121
Evolution of anal HPV infection and HPV-related squamous intraepithelial lesions in a cohort of PLWH: is there a benefit of HPV vaccination? 118
High prevalence of Hepatic Steatosis in a cohort of People Living With HIV: exploring the role of metabolic and HIV-related factors 113
Prevalence, Incidence and Predictors of Anal HPV Infection and HPV-Related Squamous Intraepithelial Lesions in a Cohort of People Living with HIV 99
An eight-year experience of Nocardia infection in Italy: does immunosuppression matter? 97
Successful treatment of complicated infective endocarditis due to Enterococcus faecium in a patient with substance use disorder using oritavancin as sequential maintenance therapy 96
Prevalence and correlates of Hepatic Steatosis and Metabolic-associated Fatty Liver Disease in a cohort of People Living With HIV 96
Use of Cefiderocol in Adult Patients: Descriptive Analysis from a Prospective, Multicenter, Cohort Study 95
Low risk for SARS-CoV2 symptomatic infection and early complications in paediatric patients during the ongoing CoVID19 epidemics in Lombardy 94
EBV DNA increase in COVID-19 patients with impaired lymphocyte subpopulation count 94
Meropenem-vaborbactam as intrathecal-sparing therapy for the treatment of carbapenem-resistant K. pneumoniae shunt-related ventriculitis: two case reports and review of the literature 94
Outcomes and Predictors of Mortality in Patients With KPC-Kp Infections Treated With Meropenem Vaborbactam: An Observational Multicenter Study 92
Early remdesivir to prevent severe COVID-19 in recipients of solid organ transplant: a real-life study from Northern Italy 90
Dynamic NLR and PLR in Predicting COVID-19 Severity: A Retrospective Cohort Study 90
Is a radiological score needed to define the severity of Nontuberculous mycobacteria lung disease? 86
Immunity to SARS-CoV-2 up to 15 months after infection 84
The Uprise of Human Leishmaniasis in Tuscany, Central Italy: Clinical and Epidemiological Data from a Multicenter Study 83
Clinical characteristics of coronavirus disease (COVID-19) early findings from a teaching hospital in Pavia, North Italy, 21 to 28 February 2020 81
Integrase Inhibitors Use and Cytomegalovirus Infection Predict Immune Recovery in People Living With HIV Starting First-Line Therapy 80
Correction to: Venous thromboembolism and COVID-19: a single center experience from an academic tertiary referral hospital of Northern Italy (Internal and Emergency Medicine, (2021), 16, 5, (1141-1152), 10.1007/s11739-020-02550-6) 78
Rapid response to COVID-19 outbreak in Northern Italy: how to convert a classic infectious disease ward into a COVID-19 response centre 75
Mortality due to COVID-19 during the pandemic: A comparison of first, second and third SMAtteo COvid19 REgistry (SMACORE) 75
Circulating endothelial cells in COVID-19 75
Lack of SARS-CoV-2 RNA environmental contamination in a tertiary referral hospital for infectious diseases in Northern Italy 71
SARS-CoV-2 specific T-cell immunity in COVID-19 convalescent patients and unexposed controls measured by ex vivo ELISpot assay 71
Persistence of SARS-CoV-2-specific B and T cell responses in convalescent COVID-19 patients 6–8 months after the infection 71
SARS Cov-2 infection in a renal-transplanted patient: A case report 65
Performance of VivaDiag COVID‐19 IgM/IgG Rapid Test is inadequate for diagnosis of COVID‐19 in acute patients referring to emergency room department 65
Competing-risk analysis of coronavirus disease 2019 in-hospital mortality in a Northern Italian centre from SMAtteo COvid19 REgistry (SMACORE) 65
The infection risk after transjugular intrahepatic portosystemic shunt: A multiple competing risk analysis from a tertiary care center 64
Patients with chronic hepatitis C receiving treatment with direct acting antivirals: How is this population changing? 63
Severe acute respiratory syndrome coronavirus 2 RNA contamination of inanimate surfaces and virus viability in a health care emergency unit 62
Emergency Department and Out-of-Hospital Emergency System (112—AREU 118) integrated response to Coronavirus Disease 2019 in a Northern Italy centre 55
Predictors of starting antimicrobial treatment in patients with nontuberculous mycobacterial lung disease in the Italian scenario: A SITA GIOVANI-IRENE promoted web-survey 51
Pharmacokinetic profile of dolutegravir after transjugular intrahepatic portosystemic shunt placement 50
Totale 3.525
Categoria #
all - tutte 9.180
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 9.180


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/202214 0 0 0 0 0 0 0 0 0 0 9 5
2022/202327 2 4 3 8 0 5 1 1 3 0 0 0
2023/202447 1 0 6 7 2 12 11 1 2 1 0 4
2024/20251.217 5 6 10 7 226 89 138 70 56 52 120 438
2025/20262.220 290 590 383 451 487 19 0 0 0 0 0 0
Totale 3.525